OFFICIAL PUBLICATION OF

by its subsidiary APPco

Bactroban shortage over

Chris Brooker 30/08/2017

Production issues now resolved, manufacturer tells TGA Manufacturing issues that led to a shortage of the impetigo treatment Bactroban have been resolved, the TGA says. GSK, manufacturer of the treatment has advised that “the shortage of Bactroban (mupirocin) 20 mg/g ointment tube has been resolved”. “Manufacturing issue that resulted in the unavailability of the medicine

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Bactroban shortage over

Previous "Addiction cannot be cured by a punitive measure."

Next Time out: slapdown for pharmacy radio critic

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous "Addiction cannot be cured by a punitive measure."

Next Time out: slapdown for pharmacy radio critic

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.